Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
1(25%)
Results Posted
0%(0 trials)
Terminated
1(25%)

Phase Distribution

Ph not_applicable
2
50%
Ph phase_4
1
25%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution3 total trials
Phase 4Post-market surveillance
1(33.3%)
N/ANon-phased studies
2(66.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(2)
Completed(1)
Terminated(1)

Detailed Status

Completed1
Not yet recruiting1
Recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
50.0%
Most Advanced
Phase 4

Trials by Phase

Phase 41 (33.3%)
N/A2 (66.7%)

Trials by Status

completed125%
not_yet_recruiting125%
recruiting125%
terminated125%

Recent Activity

1 active trials
Showing 4 of 4
recruitingnot_applicable

A Study of Time-Restricted Eating in Childhood Cancer Survivors

NCT07009288
not_yet_recruitingnot_applicable

Determination of New Detection and Quantification Thresholds for Serological and Molecular Tests for Hepatitis Delta Virus (HDV) Using Capillary Blood on Blotting Paper (DBS)

NCT06649396
terminatedphase_4

Dose Tapering Study of Adalimumab in Psoriasis

NCT04028713
completed

Prevalence Survey of Antimalarial Drug Resistance Markers

NCT03217851

Clinical Trials (4)

Showing 4 of 4 trials
NCT07009288Not Applicable

A Study of Time-Restricted Eating in Childhood Cancer Survivors

Recruiting
NCT06649396Not Applicable

Determination of New Detection and Quantification Thresholds for Serological and Molecular Tests for Hepatitis Delta Virus (HDV) Using Capillary Blood on Blotting Paper (DBS)

Not Yet Recruiting
NCT04028713Phase 4

Dose Tapering Study of Adalimumab in Psoriasis

Terminated
NCT03217851

Prevalence Survey of Antimalarial Drug Resistance Markers

Completed

All 4 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
4